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Osteoporosis affects most commonly postmenopausal women, placing them at a
significant risk for fractures. It is well known that osteoporotic fractures frequently
occur at the skeletal sites including the spine, hip, and distal radius. Thus, evolving
a strategy for the prevention of these osteoporotic fractures would appear to be
important in postmenopausal women with osteoporosis.
Up to now, numerous preclinical studies on postmenopausal osteoporosis have
shown the influence of an ovariectomy (OVX) on the skeleton in animals and the
effect of intervention on the skeleton in OVX animals. It has been suggested that
OVX nonhuman primates are a good model for postmenopausal osteoporosis
because their trabecular and cortical bone remodeling processes, monthly menstrual
cycles, and reproductive hormone patterns are similar to those of humans.
1-5 In
particular, Jerome et al.
5 have shown that OVX cynomolgus monkeys are an
excellent model for studying the basic mechanism of postmenopausal osteoporosis
and for the development of suitable therapeutic regimens. Peak bone mass is
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Purpose: To examine the influence of ovariectomy (OVX) on bone turnover and trabecular bone mass at the 3
clinically important skeletal sites in mature cynomolgus monkeys. Materials and Methods: Six female
cynomolgus monkeys, aged 17-21 years, were randomized into 2 groups by the stratified weight: the OVX and
sham-operation groups (n = 3 in each group). The experimental period was 16 months. Lumbar bone mineral
density (BMD) in vivo and serum and urinary bone turnover markers were longitudinally measured, and peripheral
quantitative computed tomographic and bone histomorphometric analyses were performed on trabecular bone of the
lumbar vertebra, femoral neck, and distal radius at the end of the experiment. Results: OVX induced in a reduction
in lumbar BMD compared with the sham controls and the baseline, as a result of increased serum levels of bone-
specific alkaline phosphatase and urinary levels of cross-lined N- and C-terminal telopeptides of type I collagen.
Furthermore, OVX induced reductions in trabecular volumetric BMD and trabecular bone mass compared with the
sham controls, with increased bone formation rate at the lumbar vertebra, femoral neck, and distal radius.
Conclusion: The results indicated that OVX in mature cynomolgus monkeys (17-21 years of age) increased bone
turnover and induced trabecular bone loss at the three skeletal sites compared with the sham controls. Thus, mature
cynomolgus monkeys could be utilized for preclinical studies to examine the effects of interventions on bone
turnover and trabecular bone mass at the 3 clinically important skeletal sites.
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358reached in female cynomolgus monkeys at 9 years of age,
6
2-3 years after growth plate closure, and animals older than
this age would be an ideal for studies designed to model
skeletally mature women.
7 The lumbar spine has been most
frequently studied in cynomolgus monkeys by measuring
bone mineral density (BMD) using dual energy X-ray
absorptiometry (DXA).
8 However, little data exist on the
influence of OVX on the 3 clinically important skeletal sites
such as the lumbar vertebra, femoral neck, and distal radius
in mature cynomolgus monkeys.
Because bone loss at the skeletal site rich in trabecular
bone after OVX appears to be more pronounced than that at
the skeletal site rich in cortical bone in cynomolgus mon-
keys,
9 a statistically significant loss of trabecular bone mass
could be detected at the above described 3 sites even with a
smaller sample size. From the point of research and develop-
ment (R&D) view, it is important to establish the influence
of OVX on the clinically important skeletal sites in mature
monkeys. The purpose of the present study was to examine
the influence of OVX on bone turnover and trabecular bone
mass at the 3 clinically important skeletal sites in mature
cynomolgus monkeys.
Treatment of animals
The study was carried out at the Animal Facility of the Simian
Conservation Breeding & Research Center (SICONBREC),
Inc., Philippines, and the animals were maintained according
to the National Institutes of Health (NIH) Guidelines for
Care and Use of Laboratory Animals. All the animal proto-
cols were approved by the Laboratory Animal Care Com-
mittee of SICONBREC Inc., Philippines.
Six wild-caught female cynomolgus monkeys which had
been used for breeding at SICONBREC (Macaca Fasci-
cularis, conventional grade) were housed individually in
bracket cages (500 mm in width; 500 mm in depth; 750 mm
in height) and used for the study after quarantine and
acclimation. Because nonhuman primates have menstrual
cycles until near the end of their maximum life span,
10 all of
them had regular menstruation. According to dentition, their
estimated ages ranged from 17 to 21 years. The animals
were housed under local vivarium conditions (temperature
26 ± 4˚C, humidity 75 ± 25% and 12 h on/off light cycle),
and were fed a 100 g Standard Monkey Breeder Pellets
containing 0.93% calcium and 0.77% phosphorus (Repub-
lic Flour Mills Corp., Makati City, Philippines) once a day
and given in-house pumped water ad libitum.
After allowing 1-month’s adaptation to the new environ-
ment, the monkeys were randomized into 2 groups of 3
monkeys each by the stratified weight method: the OVX
group and the sham-operation (Sham) group. After intramus-
cular anesthesia with a mixed solution of ketamine hydro-
chloride and xylazine (Troy Laboratories PTY Limited,
NSW, Australia) at the dose of 10 mg/kg each, bilateral
OVX and a sham-operation were performed for the OVX
and Sham groups, respectively. The body weight of the
monkeys was monitored weekly and the experimental
period was 16 months (64 weeks).
The following parameters were mainly evaluated in the
present study; serum and urinary bone turnover markers,
lumbar BMD and bone mineral content (BMC) in vivo by
DXA, trabecular volumetric BMD (vBMD) of the lumbar
vertebra, femoral neck, and distal radius by peripheral quan-
titative computed tomography (pQCT), trabecular bone
mass and dynamics of the lumbar vertebra, femoral neck, and
distal radius by static and dynamic bone histomorphometry,
and bone strength of the lumbar vertebra and femoral neck.
Biochemical analysis of serum and urine
Serum and urine samples were collected in the morning after
fasting from every animal at the baseline and 16, 32, 48, 53,
and 64 weeks after the start of the experiment. In particular,
urine excreted for 24 hours was collected using metabolic
cages. Serum and urine samples were stored at -70˚C, and
then used for the measurements of the following bioche-
mical markers.
Serum and urinary levels of calcium and phosphorus
were measured by the o-cresolphthalein complexone
(OCPC) and Fiske-Subbarow methods, respectively using
an auto analyzer 7060E (Hitachi Lt., Tokyo, Japan). Serum
levels of alkaline phosphatase (ALP) and creatinine and
urinary levels of creatinine were measured by the enzyme
method using the Auto analyzer 7060E. Serum levels of
bone-specific ALP were measured with an enzyme-linked
immunosorbent assay (ELISA) method using Osteolinks
BAP (Sumitomo Biomedical Co., Ltd., Osaka, Japan). Serum
and urinary levels of cross-linked N-terminal telopeptides
of type I collagen (NTX) were measured with an ELISA
using Osteomark NTX for serum and urine, respectively
(Mochida Pharmaceutical Co., Ltd., Tokyo, Japan). Urinary
levels of cross-linked C-terminal telopeptides of type I
collagen (CTX) were measured with an ELISA using
Furelisa β crosslaps (Fujirebio Inc., Tokyo, Japan). Serum
levels of intact parathyroid hormone (iPTH) were measured
with an ELISA method using I-PTH ELISA (Diagnostic
Systems Laboratories Inc., Texas, USA).
Lumbar BMD and BMC measurement in vivo by DXA
DXA scanning of the lumbar spine was performed in vivo
at the baseline and 16, 32, 53, and 62 weeks after the start of
the experiment. The procedure used for scanning was based
on the method previously described.
9 After anesthesia with
an intramuscular injection of a mixed solution of ketamine
hydrochloride and xylazine, the lumbar spine (L1-L7) was
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MATERIALS AND METHODSscanned by DXA using a DPX-alpha (Lunar Ltd., Madison,
WI, USA), with the animals supine on a Styrofoam board
together with tap water 10 cm deep. The instrument was set
up in a pediatric anteroposterior spine mode (setting: 8 cm
scan width, 6 cm/s scan speed, and 0.6 mm×0.6 mm pixel
size). The BMD and BMC of the lumbar spine (L4-L6)
were determined.
Preparation of bone specimens and measurement of
uterus, liver and kidney weight
All the monkeys were labeled with 4 mg/kg of calcein (Dojin
Chemical Laboratories Co., Ltd., Kumamoto, Japan) injected
intravenously 22 days and 9 days before they were sacrificed.
At 64 weeks after the start of the experiment, the animals
were anesthetized by intramuscular injection of a mixed
solution of ketamine hydrochloride and xylazine, and sacri-
ficed by exsanguination. The uterus, liver, and bilateral
kidneys were excised from every animal, and their wet
weight was measured. The 3rd, 4th and 5th lumbar spines,
bilateral femurs, tibiae and forearm bones were also excised
from every animal. Immediately, the length of the left femur
and tibia was measured with dial calipers. The 4th lumbar
vertebra, left femur, and right forearm bone were stored at
-20˚C, and then processed for pQCT analysis of trabecular
bone of the lumbar vertebra, femoral neck, and distal radius.
The 5th lumbar vertebra was stored at -20˚C and then pro-
cessed for biomechanical testing of the lumbar vertebra.
The left femur was also processed for biomechanical testing
of the femoral neck immediately after pQCT analysis. The
3rd lumbar vertebra, right femur, and left forearm bone
were fixed in 70% cold ethanol, and then processed for
bone histomorphometric analysis of trabecular bone of the
lumbar vertebra, femoral neck, and distal radius.
Bone histomorphometric analysis of trabecular bone of
the lumbar vertebra, femoral neck, and distal radius
The bones fixed in 70% cold ethanol were cut using an
Isomet saw (Buehler, Lake Bluff, IL, USA) to obtain speci-
mens of the lumbar vertebra, femoral neck, and distal
radius. The bone specimens were stained with Villanueva
Osteochrome Bone Stain (Polyscience, Warrington, PA,
USA) for 5 days. The specimens were then dehydrated
sequentially in ascending concentrations of ethanol (70%,
95%, and 100%) and xylene and then embedded in methyl
methacrylate (EM Science, Gibbstown, NJ, USA) at 4˚C by
the method of Erben.
11 The frontal-sections of the femoral
neck, the sagittal sections of the center of the lumbar vertebra,
and the frontal sections of the distal radius were cut into 5-
µm slices using a microtome (Leica RM2155; Leica Inc.,
Nussloch, Germany), transferred onto chromium-gelatin-
coated slides, dried overnight under pressure at 42˚C, and
coverslipped with Eukitt mounting medium (Calibrated
Instruments, Hawthorne, NY, USA) for static and dynamic
histomorphometric analysis of trabecular bone.
A digitizing morphometric system was used to measure
bone histomorphometric parameters. The system consisted
of an epifluorescence microscope (Olympus BH-2), a color
video camera, and a digitizing pad (Numonics 2206) coupled
to an IBM computer, and a morphometry program (Osteo-
Metrics, Atlanta, GA, USA). The measured parameters for
trabecular bone included total tissue volume (TV), bone
volume (BV), bone surface (BS), eroded surface (ES), single-
and double-labeled surfaces (sLS and dLS, respectively),
and interlabel width. These data were used to calculate
percent trabecular bone volume (BV/TV), trabecular
number (TbN), trabecular thickness (Tb Th), trabecular
separation (Tb Sp), ES/BS, mineralizing surface (MS)/BS
[(sLS/2+dLS)/BS], mineral apposition rate (MAR), bone
formation rate (BFR)/BS, and BFR/BV in accordance with
the standard nomenclature proposed by Parfitt et al.
12 In the
present study, the region of trabecular bone measured was
1.55-5.95 mm distal from the center of growth plate, which
consists of secondary spongiosa.
pQCT analysis of trabecular bone of the lumbar 
vertebra, femoral neck, and distal radius
The lumbar vertebra, femoral neck, and distal radius were
scanned with pQCT (XCT Research SA+; Stratec Medizin-
technic GmbH, Pforzheim, Germany) in 50% ethanol/
saline. The bones were placed inside a glass tube and
scanned at a slice thickness of 0.77 mm and voxel size of
0.4 mm. The middle parts of the lumbar vertebra and femoral
neck were scanned. For the distal radius, the skeletal site
distant from the distal joint by a length corresponding to 4%
of the bone length was scanned. The scan line was adjusted
using the scout view of the pQCT system. For analysis, a
threshold of 395 mg/cm
3 at contour mode 2 was used to
separate the bone areas from the marrow regions. To separate
the cortical areas from the trabecular areas, we used a
constant threshold of 690 mg/cm
3. Total and trabecular
vBMD and area were measured.
Biomechanical testing of the lumbar vertebra and 
femoral neck
The mechanical strength of the lumbar vertebra and femoral
neck was evaluated by the compression test using a materials-
testing machine (MZ-500S; Maruto, Co., Ltd., Tokyo,
Japan). The femurs were held in the upright position on the
loading platform and a 500 kgf load was given by the
rectangular parallelepiped crosshead to the center of the
femoral head at a rate of 30 mm/min. For the lumbar verte-
bra, the intervertebral disc was removed to expose the trabe-
cular bone area which was compressed to break over 3 mm
or more. A 500 kgf load was given by the rectangular paral-
lelezpiped crosshead to the center of the lumbar vertebra at
a rate of 10 mm/min. The specimens were tested in a saline
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bath for about 3 minutes before the testing, to allow temper-
ature equilibration. Load-displacement curves were record-
ed, and the parameters analyzed were maximum load,
stiffness, and breaking energy.
Statistical analysis
The data were expressed as means ± standard deviation in
tables and means ± standard error in figures. Data com-
parisons between the 2 groups were performed with an
unpaired t-test. Longitudinal changes in lumbar BMD and
BMC and biochemical markers were examined with an
one-way analysis of variance (ANOVA) with repeated
measurements. Differences in longitudinal changes in these
parameters between the 2 groups were examined with a
two-way ANOVA with repeated measurements. All the
statistical analyses were performed using the Stat View J-
5.0 program (SAS Institute Inc., NC, USA) on a Macintosh
computer. A significance level of p < 0.05 was used for all
the comparisons.
Baseline characteristics of the animals
Table 1 shows the baseline characteristics of the animals.
There were no significant differences in initial body weight,
lumbar BMD and BMC, serum and urinary levels of cal-
cium, phosphorus, and creatinine, and serum and urinary
levels of bone turnover markers between the 2 groups.
Changes in body weight
Fig. 1 shows longitudinal changes in body weight. Body
weight significantly increased in the Sham group, but did not
significantly change in the OVX group (one-way ANOVA
with repeated measurements, Table 2). However, there was
no significant difference in changes in body weight between
the 2 groups (two-way ANOVA with repeated measure-
ments, Table 2).
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RESULTS
Table 1.Baseline Characteristics of the Animals
OVX Sham pvalue
Initial body weight (kg) 4.09 ± 0.49 4.09 ± 0.68 NS
Lumbar BMD (g/cm
2) 0.896 ± 0.100 0.968 ± 0.135 NS
Lumbar BMC (g) 8.700 ± 0.865 9.087 ± 1.885 NS
Serum
Calcium (mg/dL) 9.0 ± 1.8 9.7 ± 0.7 NS
Phosphorus (mg/dL) 2.3 ± 1.3 2.4 ± 0.6 NS
Creatinine (mg/dL) 0.62 ± 0.27 0.79 ± 0.02 NS
ALP (IU/L) 510 ± 75 616  ± 150 NS
Bone-specific ALP (U/L) 67.6 ± 11.7 75.9 ± 21.4 NS
NTX (nmol BCE/L) 10.1 ± 4.4 16.0 ± 5.4 NS
iPTH (pg/mL) 7.2 ± 6.8 24.4 ± 17.5 NS
Urine
Calcium / Cr 1.16 ± 0.07 0.97 ± 0.34 NS
Phosphorus / Cr 0.017 ± 0.010 0.009 ± 0.008 NS
NTX (nmol BCE / mmol Cr) 35.7 ± 7.3 49.4 ± 20.1 NS
CTX (µg / mmol Cr ) 381 ± 157 400 ± 65 NS
OVX, ovariectomy; BMD, bone mineral density; BMC, bone mineral content; ALP, alkaline phosphatase; NTX, cross-linked N-terminal 
telopeptides of type I collagen; iPTH, intact parathyroid hormone; CTX, cross-linked C-terminal telopeptides of type I collagen; Cr,
creatinine; NS, not significant.
Data are expressed as means ± standard deviation. Unpaired t-test was used to compare the data between the two groups.
Fig. 1. Changes in body weight. Data are expressed as means ±standard error.
Body weight significantly increased in the Sham group, but did not in the OVX
group {one-way analysis of variance (ANOVA) with repeated measurements,
Table 2}. There was no significant difference in changes in body weight between
the 2 groups (two-way ANOVA with repeated measurements, Table 2). OVX,
ovariectomy.Changes in lumbar BMD and BMC
Fig. 2 shows longitudinal changes in the lumbar BMD and
BMC. Lumbar BMD significantly decreased in the OVX
group, but did not significantly change in the Sham group
(one-way ANOVA with repeated measurements, Table 2).
Lumbar BMC significantly increased in the Sham group,
but did not significantly change in the OVX group (one-
way ANOVA with repeated measurements, Table 2). There
was a significant difference in changes in the lumbar BMD
and BMC between the 2 groups (two-way ANOVA with
repeated measurements, Table 2). Thus, OVX induced not
only relative osteopenia but also absolute osteopenia, as
indicated by a reduction in lumbar BMD compared with
Sham controls and the baseline, respectively.
Changes in serum and urine biochemical markers
Fig. 3 shows longitudinal changes in the serum and urinary
levels of bone turnover markers. Serum and urinary NTX
levels significantly increased, while urinary CTX levels did
not significantly change in both groups (one-way ANOVA
with repeated measurements, Table 2). Bone-specific ALP
levels significantly increased in the OVX group, but signi-
ficantly decreased in the Sham group (one-way ANOVA
with repeated measurements, Table 2). There were signifi-
cant differences in changes in urinary NTX and CTX levels
and serum bone-specific ALP levels, but not in those in
serum NTX levels, between the 2 groups (two-way ANOVA
with repeated measurements, Table 2).
Fig. 4 shows longitudinal changes in the serum levels of
Table 2.One-way and Two-way ANOVA with Repeated Measurements
One-way ANOVA Two-way ANOVA
OVX Sham OVX vs. Sham
Body weight NS < 0.05 NS
Lumbar BMD < 0.01 NS < 0.01
Lumbar BMC NS < 0.05 < 0.05
Serum
Calcium NS NS NS
Phosphorus NS NS NS
ALP < 0.01 NS NS
Bone-specific ALP < 0.01 < 0.05 < 0.01
NTX < 0.001 < 0.01 NS
iPTH < 0.001 NS NS
Urine
Calcium / Cr NS NS NS
Phosphorus / Cr NS NS NS
NTX < 0.0001 < 0.01 < 0.001
CTX NS NS < 0.05 
ANOVA, analysis of variance; OVX, ovariectomy; BMD, bone mineral density; BMC, bone mineral content; ALP, alkaline phosphatase; 
NTX, cross-linked N-terminal telopeptides of type I collagen; iPTH, intact parathyroid hormone; CTX, cross-linked C-terminal
telopeptides of type I collagen; NS, not significant.
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Fig. 2.Changes in lumbar BMD and BMC. Data are expressed as means ±standard error. Lumbar BMD significantly decreased in the OVX group, but did not change in
the Sham group {one-way analysis of variance (ANOVA) with repeated measurements, Table 2}. Lumbar BMC significantly increased in the Sham group, but did not
significantly change in the OVX group (one-way ANOVA with repeated measurements, Table 2). There was a significant difference in changes in lumbar BMD and BMC
between the 2 groups (two-way ANOVA with repeated measurements, Table 2). OVX: ovariectomy, BMD, bone mineral density; BMC, bone mineral content. 
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Fig. 3. Changes in serum and urinary levels of bone turnover markers. Data are expressed as means ± standard error. Serum and urinary NTX levels significantly
increased and urinary CTX levels did not in both groups {one-way analysis of variance (ANOVA) with repeated measurements, Table 2}. Bone-specific ALP levels
significantly increased in the OVX group, but significantly decreased in the Sham group (one-way ANOVA with repeated measurements, Table 2). There were
significant differences in changes of urinary NTX and CTX levels and serum bone-specific ALP levels, but not in those in serum NTX levels, between the 2 groups (two-
way ANOVA with repeated measurements, Table 2). OVX, ovariectomy; NTX, cross-linked N-terminal telopeptides of type I collagen; CTX, cross-linked C-terminal
telopeptides of type I collagen; Cr, creatinine; ALP, alkaline phosphatase.
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Fig. 4. Changes in serum levels of calcium, phosphorus, ALP, and iPTH. Data are expressed as means ±standard error. Serum calcium and phosphorus levels did not
significantly change in the both groups {one-way analysis of variance (ANOVA) with repeated measurements, Table 2}. Serum ALP and iPTH levels significantly
increased in the OVX group, but did not change in the Sham group (one-way ANOVA with repeated measurements, Table 2). There were no significant differences in
changes in serum calcium, phosphorus, ALP and iPTH levels between the 2 groups (two-way ANOVA with repeated measurements, Table 2). OVX, ovariectomy; ALP,
alkaline phosphatase; iPTH, intact parathyroid hormone.calcium, phosphorus, ALP, and iPTH. Serum calcium and
phosphorus levels did not significantly change in both
groups (one-way ANOVA with repeated measurements,
Table 2). Serum ALP and iPTH levels significantly increas-
ed in the OVX group, but did not significantly change in the
Sham group (one-way ANOVA with repeated measure-
ments, Table 2). There were no significant differences in
changes in serum calcium, phosphorus, ALP, and iPTH
levels between the 2 groups (two-way ANOVA with repeat-
ed measurements, Table 2).
Fig. 5 shows longitudinal changes in the urinary levels of
calcium and phosphorus. Urinary calcium/Cr and phos-
phorus/Cr did not significantly change in both groups (one-
way ANOVA with repeated measurements, Table 2). There
were no significant differences in changes in urinary calcium/
Cr and phosphorus/Cr between the 2 groups (two-way
ANOVA with repeated measurements, Table 2).
Final body weight, femoral and tibial length, and uterus,
liver, and kidney weight at necropsy
Table 3 shows final body weight, femoral and tibial length,
and uterus, liver, and kidney weight at necropsy. There were
no significant differences in final body weight, femoral and
tibial length, or liver and kidney weight. However, the uterus
weight was significantly lower in the OVX group than in
the Sham group, suggesting successful surgery in the OVX
group.
Bone histomorphometric analysis of trabecular bone of
the lumbar vertebra, femoral neck, and distal radius
Table 4 shows the results of static and dynamic bone
histomorphometric analysis of trabecular bone of the
lumbar vertebra, femoral neck, and distal radius. BV/TV of
the lumbar vertebra, femoral neck, and distal radius was
significantly lower in the OVX group than in the Sham
group, which was associated with increased BFR/BV. How-
ever, the response of trabecular bone structural parameters
and bone formation and erosion parameters differed among
the skeletal sites.
pQCT analysis of trabecular bone of the lumbar vertebra,
femoral neck, and distal radius
Table 5 shows the results of pQCT analysis of trabecular
bone of the lumbar vertebra, femoral neck, and distal radius.
Trabecular vBMD of the lumbar vertebra, femoral neck, and
distal radius was lower in the OVX group than in the Sham
group. In particular, the total area of the femoral neck was
greater in the OVX group than in the Sham group,
suggesting cortical expansion in the femoral neck caused by
OVX.
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Fig. 5. Changes in urinary levels of calcium and phosphorus. Data are expressed as means ±standard error. Urinary calcium/Cr and phosphorus/Cr did not significantly
change in the both groups {one-way analysis of variance (ANOVA) with repeated measurements, Table 2}. There were no significant differences in changes in urinary
calcium/Cr and phosphorus/Cr between the 2 groups (two-way ANOVA with repeated measurements, Table 2). OVX, ovariectomy; Cr, creatinine.
Table 3.Final Body Weight, Femoral and Tibial Length, and Uterus, Liver, and Kidney Weight at Necropsy
OVX Sham pvalue
Final body weight (kg) 3.95 ± 0.45 4.33 ± 1.02 NS
Femoral length (cm) 13.9 ± 0.3 14.1 ± 0.8 NS
Tibial length (cm) 12.6 ± 0.2 12.7 ± 0.9 NS
Uterus weight (g) 1.77 ± 0.41 9.15 ± 1.84 < 0.01
Liver weight (g) 91.9 ± 9.9 86.3 ± 6.6 NS
Right kidney weight (g) 11.1 ± 1.3 9.4 ± 1.4 NS
Left kidney weight (g) 11.3 ± 1.5 9.2 ± 2.1 NS
OVX, ovariectomy NS, not significant. 
Data are expressed as means ± standard deviation. Unpaired t-test was used to compare the data between the two groups.Biomechanical analysis of the lumbar vertebra and
femoral neck
Table 6 shows the results of biomechanical testing of the
lumbar vertebra and femoral neck. There were no signifi-
cant differences in the maximum load, stiffness, and breaking
energy of the lumbar vertebra and femoral neck between
the 2 groups. The lack of any significant differences in the
parameters might be attributable to the low statistical power
due to the small sample size.
The present study clearly demonstrated that OVX in mature
cynomolgus monkeys, aged 17-21 years, increased bone
turnover markers such as serum bone-specific ALP and
urinary NTX and CTX, and induced trabecular bone loss
associated with increased BFR/BV compared with Sham
controls at the lumbar vertebra, femoral neck, and distal
radius. OVX induced not only relative osteopenia but also
absolute osteopenia as indicated by a reduction in lumbar
BMD compared with Sham controls and the baseline, res-
pectively, confirming that mature cynomolgus monkeys
could be utilized for preclinical studies of postmenopausal
osteoporosis to examine the effects of interventions on bone
turnover and trabecular bone mass at the 3 clinically impor-
tant skeletal sites. Thus, we support the concept that nonhu-
man primates are a good model for postmenopausal osteo-
porosis based on densitometric, histomorphometric and
serum bone marker analysis.
7
Concern has been expressed that the OVX monkey
model does not produce consistent, statistically significant
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DISCUSSION
Table 4.Bone Histomorphometric Analysis of Trabecular Bone of the Lumbar Vertebra, Femoral Neck, and Distal Radius
Lumbar vertebra Femoral neck Distal radius
OVX Sham pvalue OVX Sham pvalue OVX Sham pvalue
BV / TV (%) 22.2 ± 0.9 31.6 ± 1.9 < 0.01 17.8 ± 1.0 33.5 ± 9.0 < 0.05 9.0 ± 2.3 20.2 ± 2.0 < 0.01
TbN (1/mm) 1.95 ± 0.57 2.58 ± 0.30 NS 1.15 ± 0.14 1.49 ± 0.41 NS 1.26 ± 0.21 2.04 ± 0.29 < 0.05
Tb Th (µm) 119 ± 26 123 ± 17 NS 156 ± 18 224 ± 4 < 0.01 71 ± 7 101 ± 22 NS
Tb Sp (µm) 604 ± 158 384 ± 45 NS 1,043 ± 137 685 ± 246 NS 1,058 ± 198 569 ± 64 < 0.05
MS / BS (%) 15.7 ± 6.0 9.5 ± 5.4 NS 13.1 ± 2.6 8.9 ± 1.8 NS 27.8 ± 3.1 11.0 ± 0.7 < 0.001
MAR (µm/d) 0.86 ± 0.13 0.61 ± 0.03 < 0.05 0.68 ± 0.02 0.63 ± 0.07 NS 0.56 ± 0.04 0.54 ± 0.08 NS
BFR/BS (µm
3/µm
2/d) 13.4 ± 5.1 5.8 ± 3.3 NS 8.9 ± 1.5 5.6 ± 1.2 < 0.05 15.4 ± 0.6 5.9 ± 0.6 < 0.0001
BFR / BV (%) 67.5 ± 15.0 30.2 ± 19.5 < 0.05 34.7 ± 5.5 15.2 ± 3.4 < 0.01 132.8 ± 10.3 36.1 ± 5.0 < 0.001
ES / BS (%) 9.0 ± 2.8 7.1 ± 3.4 NS ND ND NS 11.7 ± 2.3 6.5 ± 1.5 < 0.05
OVX, ovariectomy; BV, bone volume; TV, total tissue volume; TbN, trabecular number; Tb Th, trabecular thickness; Tb Sp, trabecular separation; MS, 
mineralizing surface; BS, bone surface; MAR, mineral apposition rate; BFR, bone formation rate; ES, eroded surface; ND, not detected; NS, not
significant. 
Data are expressed as means ± standard deviation. Unpaired t-test was used to compare the data between the two groups. 
Table 5.pQCT Analysis of Trabecular Bone of the Lumbar Vertebra, Femoral Neck, and Distal Radius
Lumbar vertebra Femoral neck Distal radius
OVX Sham pvalue OVX Sham pvalue OVX Sham pvalue
Total vBMD (mg/cm
3) 438 ± 72 577 ± 56 < 0.05 718 ± 7 918 ± 97 < 0.05 470 ± 27 515 ± 17 NS
Trabecular vBMD (mg/cm
3) 259 ± 60 384 ± 45 < 0.05 287 ± 71 587 ± 170 < 0.05 123 ± 23 216 ± 24 < 0.01
Total area (mm
2) 106.9 ± 8.5 114.9 ± 14.4 NS 71.2 ± 2.4 63.6 ± 2.9 < 0.05 61.1 ± 0.1 66.1 ± 7.5 NS
Trabecular area (mm
2) 47.9 ± 4.3 51.8 ± 6.4 NS 21.4 ± 0.7 19.1 ± 0.8 < 0.05 27.5 ± 0.1 29.8 ± 3.4 NS
pQCT, peripheral quantitative computed tomography; OVX, ovariectomy; vBMD, volumetric bone mineral density; NS, not significant.
Data are expressed as means ± standard deviation. Unpaired t-test was used to compare the data between the two groups. 
Table 6.Bone Strength of the Lumbar Vertebra and Femoral Neck
Lumbar vertebra Femoral neck
OVX Sham pvalue OVX Sham pvalue
Maximum load (N) 548 ± 169 836 ± 303 NS 1,463 ± 116 1,681 ± 649 NS
Stiffness (N/m) 13,091 ± 1,463 13,730 ± 997 NS 9,260 ± 3,299 9,952 ± 3,506 NS
Breaking energy (N m10
-3) 7,257 ± 2,140 10,181 ± 3,835 NS 20,193 ± 6,171 19,871 ± 3,384 NS
OVX, ovariectomy; NS, not significant. 
Data are expressed as means ± standard deviation. Unpaired t-test was used to compare the data between the two groups. osteopenia and bone fragility, and frequently exhibits a
“failure to gain” bone, rather than the clear bone loss
expected of a model for postmenopausal osteoporosis.
8
Relative osteopenia compared with intact animals is observ-
ed in younger OVX cynomolgus monkeys who were fed a
normal calcium diet, whereas absolute osteopenia develops
in OVX cynomolgus monkeys at age > 9 years and conco-
mitantly fed a low calcium diet.
13 In the present study,
however, OVX in cynomolgus monkeys, aged 17-21 years,
induced absolute osteopenia under the condition of a normal
calcium diet (0.93%), as indicated by a reduction in lumbar
BMD from the baseline. Thus, not only the dietary calcium
content but also ages of the animals might be important to
develop absolute osteopenia in OVX cynomolgus monkeys.
Urinary levels of NTX and CTX and serum levels of
bone-specific ALP levels increased after OVX in the present
study. Previous studies have shown that OVX in cynomo-
lgus monkeys increased urinary levels of deoxypyridinoline
and serum levels of osteocalcin, ALP, bone-specific ALP,
and tartrate-resistant acid phosphatase.
5,9,14-16 However,
recent studies demonstrated OVX-induced elevations in
urinary levels of CTX in addition to the above markers in
cynomolgus monkeys.
17,18 Serum and urinary levels of bone
turnover markers were shown to increase within a few
months, peak at 6-12 months, and remain elevated for 18
months or longer.
8 All of these results indicate that OVX
rapidly increases the serum and urinary levels of bone
turnover markers and maintains this state for a couple of
years in cynomolgus monkeys, consistent with our results
(Fig. 3). However, the present study confirmed changes in
newer bone markers including urinary NTX and CTX in
OVX cynomolgus monkeys.
In the present study, trabecular vBMD and trabecular
bone mass (BV/TV) of the lumbar vertebra, femoral neck,
and distal radius were similarly lower in the OVX group
than in the Sham group. Trabecular bone loss compared
with Sham controls at the 3 skeletal sites was clearly associat-
ed with an increased bone formation rate (BFR/BV). This
result is consistent with those of the study conducted by
Jerome et al.
5,16 They reported that vertebral trabecular bone
loss was associated with dramatically increased bone forma-
tion rates, primarily caused by higher activation frequency
of basic multicellular units of bone in cynomolgus monkeys
(4-14 years of age),
5 and that OVX increased the bone
formation rates in trabecular bone obtained by iliac biopsy
in cynomolgus monkeys (5-8 years of age).
16 Thus, increased
bone formation rates appear to be observed at multiple
trabecular bone sites with bone histomorphometry.
8
Because of the small sample size, we could not detect any
significant changes after OVX in bone strength of the
lumbar vertebra and femoral neck, as observed in cynomol-
gus monkeys, aged 11-15 years.
14 Furthermore, we could not
find any significant changes after OVX in cortical bone
mass and strength of the femoral and tibial diaphysis,
evaluated by pQCT analysis and biomechanical testing
(three-point bending test), respectively (data not shown).
No significant changes in cortical bone mass as well as
cortical porosity were detected at the femoral neck and
distal radius, even though we performed histomorphometry
of cortical bone (data not shown). Jerome et al.
13 recommend-
ed a group size of 25 for studies in cynomolgus monkeys.
Thus, further studies are needed to clarify the influence of
OVX on bone strength and cortical bone mass in mature
cynomolgus monkeys. However, the statistically significant
changes in bone turnover and trabecular bone mass at the 3
clinically important skeletal sites are worth reporting in the
present study, as well as absolute osteopenia as indicated by
a longitudinal decrease in lumbar BMD from the baseline
even with a small sample size in mature cynomolgus
monkeys.
In conclusion, the present study clearly demonstrated that
OVX in mature cynomolgus monkeys, aged 17-21 years,
increased bone turnover markers and induced trabecular
bone loss compared with Sham controls at the lumbar
vertebra, femoral neck, and distal radius. OVX also induced
absolute osteopenia as indicated by a reduction in lumbar
BMD from the baseline. Thus, the results strongly indicate
that mature cynomolgus monkeys could be utilized for pre-
clinical studies of postmenopausal osteoporosis to examine
the effects of interventions on bone turnover and trabecular
bone mass at the three clinically important skeletal sites.
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